Latest news with #Perrigo


Reuters
5 days ago
- Business
- Reuters
Court says hedge fund's mistake cost it chance to sue over failed Perrigo takeover
Aug 12 (Reuters) - Hedge fund Sculptor Asset Management missed its chance to sue healthcare products giant Perrigo for alleged securities violations and cannot now opt out of a $97 million class action settlement, a U.S. appeals court ruled on Tuesday. A three-judge panel of the 3rd U.S. Circuit Court of Appeals in Philadelphia said Sculptor Master Fund Ltd and a related fund were barred from opting out of the investor class action more than three years after a deadline came and went. 'Sculptor had the opportunity to opt out early in this litigation, but it failed to do so. Having made that mistake, it has to live with the consequences,' wrote, opens new tab Circuit Judge Cheryl Ann Krause, joined by Circuit Judges Paul Matey and Peter Phipps. The hedge fund had argued that its intent to pursue its own lawsuit was clear in the record of the litigation in the federal court in New Jersey. The panel upheld a lower judge's ruling against Sculptor. Sculptor and a lawyer representing it at law firm Quinn Emanuel did not immediately respond to requests for comment, and neither did Perrigo. Grand Rapids, Michigan-based Perrigo settled the shareholder class action for $97 million last year, resolving claims that it made misrepresentations and omissions between 2015 and 2017 in connection with a failed $26 billion takeover bid by drugmaker Mylan. Perrigo has denied any wrongdoing. Sculptor held about 2.6 million shares of Perrigo stock, owning 5 percent of the company, court records show. Class action rules can require companies or individuals to formally opt out of settlements if they want to try to sue individually to seek a better deal or a win at trial. A former lawyer for Sculptor in the case said in a court declaration that her firm, King & Spalding, did not receive the class action notice explaining the process for exclusion. Still, the attorney said she had asked an associate at the firm to mail a formal opt-out letter to exclude Sculptor from the class action. The attorney said she was unable to determine whether the letter was mailed or whether it was lost en route. In addition to arguing that the record in the case showed it clearly intended to opt out, Sculptor also told the court that its actions could be deemed 'excusable neglect.' Perrigo countered in a court filing that Sculptor 'had ample knowledge of a class action and were represented by sophisticated legal counsel.' The appeals court said Sculptor "bears the burden of its former counsel's mistakes." The case is Perrigo Institutional Investor Group et al v. Joseph C. Papa et al, 3rd U.S. Circuit Court of Appeals, No. 24-2861.
Yahoo
30-07-2025
- Business
- Yahoo
Perrigo Announces Quarterly Dividend
DUBLIN, July 30, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.290 per share, payable on September 16, 2025, to shareholders of record on August 29, 2025. About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers. Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®. For more information, visit Forward-Looking Statements This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024. Perrigo Contact Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: View original content to download multimedia: SOURCE Perrigo Company plc
Yahoo
29-07-2025
- Business
- Yahoo
Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference
DUBLIN, July 29, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Canaccord Genuity 45th Annual Growth Conference, on Tuesday, August 12th at 9:00 AM EDT. Interested parties can access the webcast on the Perrigo website at About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers. Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®. For more information, visit Forward-Looking Statements This press release includes, and the matters discussed in Perrigo's presentation at the Canaccord Genuity 45th Annual Growth Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024. Perrigo Contact Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: View original content to download multimedia: SOURCE Perrigo Company plc Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17-07-2025
- Business
- Yahoo
Why Perrigo (PRGO) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics. Is This 1 Momentum Stock a Screaming Buy Right Now? Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks. Perrigo (PRGO) Dublin, Ireland-based Perrigo Company plc was formed following the December 2013 merger of Allegan, MI-based Perrigo Company with Elan Corporation. With a diversified revenue stream, the merged entity has a presence in the over-the-counter (OTC) market and wellness solutions designed to enhance individual well-being. Currently, the company's reporting segments are: PRGO boasts a Momentum Style Score of B and VGM Score of B, and holds a Zacks Rank #2 (Buy) rating. Shares of Perrigo has seen some interesting price action recently; the stock is down 0.5% over the past one week and up 2.9% over the past four weeks. And in the last one-year period, PRGO has lost 2.3%. As for the stock's trading volume, 867,162 shares on average were traded over the last 20 days. Momentum investors don't just pay attention to price changes; positive earnings play a crucial role, too. Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.04 to $3.04 per share. PRGO boasts an average earnings surprise of 4.4%. Investors should take the time to consider PRGO for their portfolios due to its solid Zacks Ranks, notable earnings metrics, and impressive Momentum and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Perrigo Company plc (PRGO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Malaysian Reserve
01-07-2025
- Business
- Malaysian Reserve
Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance
Company to Scale and Optimize Global Category-Led, Market Activation Growth Model Roberto Khoury, EVP & President Consumer Self-Care International (CSCI), Appointed to New Position of EVP & Chief Commercial Officer to Lead Global Market Activation Triona Schmelter, EVP & President Consumer Self-Care Americas (CSCA), to Leave Organization DUBLIN, July 1, 2025 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that it is scaling and optimizing its proven growth model—anchored in global Category Leadership and Market Activation—across the organization to enhance agility, accelerate innovation, and drive long-term sustainable growth. This organizational alignment advances Perrigo's multi-year Stabilize, Streamline and Strengthen ('Three-S') plan and reflects operational readiness across the Company. 'This is an important next step forward for Perrigo,' said Patrick Lockwood-Taylor, President and CEO. 'By aligning our organization around global categories and empowering market activation, we are positioning Perrigo to drive long-term performance with deeper customer and consumer engagement. This move links the organization to our strategy of scaling more molecules, more efficiently, to more consumers across more markets. This alignment is not just about structure—it's about performance, purpose and unlocking the full potential of our people and our portfolio.' Key Highlights of Our Category-Led, Market Activation Growth Model: Streamlining for Long-Term Sustainable Growth: This alignment enhances speed, agility and scalability, while reducing bureaucracy. It enables Perrigo to serve more consumers across a broader range of price points. Growth Model Already Delivering Strong Results: This is not a new direction. Perrigo has already realized measurable success with this model in its CSCI business and increasingly in its CSCA business, including accelerated regulatory milestones, digital activations and go-to-market strategies that have captured market opportunities and driven share gains. Unlocking the Full Potential of Our Portfolio: This alignment is designed to unlock value from both brand and store brand portfolios, creating new opportunities for growth, innovation and efficiency. Perrigo is centralizing and enhancing its global brand-building capabilities to deliver self-care solutions that consumers want—powered by deep insights, preferred innovation and impactful marketing. Execution will be driven by market-empowered activation, commercial go-to-market excellence and strong customer relationships. Aligning Leadership to Deliver Execution Excellence: To support this alignment, including category strategy execution, go-to-market excellence and global demand generation across all regions, Roberto Khoury has been appointed EVP and Chief Commercial Officer. Mr. Khoury has a strong track record of success leading Perrigo's CSCI business and will play a key role in aligning commercial functions with the new global category model. Mr. Khoury will assume responsibility for operating results in both CSCI and CSCA and will partner closely with David Ball, EVP and Chief Brand and Digital Officer, who is responsible for global category leadership. Financial Guidance Unchanged: This alignment does not impact our full-year 2025 adjusted EPS guidance or reporting segments. As part of this alignment, the roles of EVP and President CSCI and EVP and President CSCA will be discontinued. Triona Schmelter will depart the organization and be available on a consultative basis until October 31, 2025. Perrigo extends its sincere gratitude for her leadership and contributions over the past two years, including the launch of Opill® which was a significant inflection point for CSCA and women's reproductive health in the U.S. 'I want to recognize Triona's contributions in navigating the complexities of the infant formula market and strengthening our store brand position. We wish her all the best in her future endeavors,' added Lockwood-Taylor. This alignment will follow all applicable information and consultation processes, as legally required, and is expected to be implemented over the coming months. About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms and value tiers. Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®. For more information, visit Forward-Looking Statements This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under 'Risk Factors' in the Company's Form 10-K for the year ended December 31, 2024. Perrigo Contact Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: [email protected] Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: [email protected]